ea0042oc17 | (1) | Androgens2016
Latonen Leena
, Gillen Andrew
, Valkonen Mira
, Ruusuvuori Pekka
, Zhang Fuping
, Poutanen Matti
, Visakorpi Tapio
The androgen receptor (AR) signaling pathway is central to the emergence of castration-resistant prostate cancer (CRPC). miR-32 is an androgen regulated miRNA which is differentially expressed in CRPC compared to benign prostatic hyperplasia (BPH) and able to provide a significant growth advantage to LNCaP cells. To study how increased miR-32 expression contributes to prostate cancer formation and/or progression in vivo, we have established transgenic mice expressing ...